TETROTOX Trademark

Trademark Overview


On Monday, September 13, 2004, a trademark application was filed for TETROTOX with the United States Patent and Trademark Office. The USPTO has given the TETROTOX trademark a serial number of 79007266. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Saturday, September 13, 2014. This trademark is owned by NANNING MAPLE LEAF PHARMACEUTICAL CO. LTD.. The TETROTOX trademark is filed in the Pharmaceutical Products category with the following description:

Anaesthetics for surgical use, non surgical use, general, local and topical anaesthetics; syrups, namely, anaesthetic syrups, analgesic syrups, and syrups for the suppression of symptoms of drug withdrawal and for abstaining from narcotics and other drugs; chemico-pharmaceutical and pharmaceutical preparations, namely, anaesthetics and analgesics for the treatment of pain, or irritation from mechanical, chemical or ischemic stimulation, or inflammation, and for the treatment of withdrawal symptoms, the treatment of drug dependency, and for abstaining from narcotics and other drugs; salts of biologically active organic compounds for medical purposes; gelatine based dosage forms containing pharmaceutical or chemico-pharmaceutical preparations or medicines for the treatment of pain and irritation and for the treatment of drug dependency and suppression of the symptoms of drug withdrawal; lozenges and pastilles for medical purposes, namely medicated lozenges, cough lozenges, throat lozenge...
tetrotox

General Information


Serial Number79007266
Word MarkTETROTOX
Filing DateMonday, September 13, 2004
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSaturday, September 13, 2014
Registration Number3093372
Registration DateTuesday, May 16, 2006
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 21, 2006

Trademark Statements


Goods and ServicesAnaesthetics for surgical use, non surgical use, general, local and topical anaesthetics; syrups, namely, anaesthetic syrups, analgesic syrups, and syrups for the suppression of symptoms of drug withdrawal and for abstaining from narcotics and other drugs; chemico-pharmaceutical and pharmaceutical preparations, namely, anaesthetics and analgesics for the treatment of pain, or irritation from mechanical, chemical or ischemic stimulation, or inflammation, and for the treatment of withdrawal symptoms, the treatment of drug dependency, and for abstaining from narcotics and other drugs; salts of biologically active organic compounds for medical purposes; gelatine based dosage forms containing pharmaceutical or chemico-pharmaceutical preparations or medicines for the treatment of pain and irritation and for the treatment of drug dependency and suppression of the symptoms of drug withdrawal; lozenges and pastilles for medical purposes, namely medicated lozenges, cough lozenges, throat lozenges, and lozenges and pastilles containing pharmaceutical or chemico-pharmaceutical preparations; medically prescribed or legally available synthetic narcotics; medically prescribed or legally available narcotics for the treatment of pain and irritation and for the treatment of drug dependency and suppression of the symptoms of drug withdrawal; ointments and lotions for pharmaceutical purposes, namely, anti-itch ointments, haemorrhoidal ointments, medicated rash ointments, ointments and lotions for the treatment of pain, irritation or discomfort; pectin containing preparations for pharmaceutical purposes, namely, anaesthetics and analgesics for the treatment of pain, irritation from mechanical, chemical or ischemic stimulation, or inflammation, and preparations for the treatment of withdrawal symptoms, the treatment of drug dependency, and for abstaining from narcotics and other drugs; pills for pharmaceutical purposes, namely for the administration of pharmaceutical and chemico-pharmaceutical preparations in the nature of anaesthetics, analgesics and anti-irritant drugs, and preparations for the treatment of pain and drug dependency; poisons namely biological toxins or synthetic analogues or derivatives thereof for the treatment or amelioration of medical conditions, pain, irritation or discomfort, and for abstaining from drug dependency; sedatives; suppositories; medicines for human purposes, namely, anaesthetics and analgesics, for the treatment of pain, irritation from mechanical, chemical or ischemic stimulation and inflammation, and preparations for the treatment of withdrawal symptoms, the treatment of drug dependency, and for abstaining from narcotics and other drugs; biological preparations for medical purposes; chemical preparations for pharmaceutical purposes; gases for medical purposes; chemical preparations for medical purposes; chemical reagents for medical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 6, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNANNING MAPLE LEAF PHARMACEUTICAL CO. LTD.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCN

Party NameNANNING MAPLE LEAF PHARMACEUTICAL CO. LTD.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCN

Party NameNANNING MAPLE LEAF PHARMACEUTICAL CO. LTD.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events


Event DateEvent Description
Monday, June 1, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Friday, April 10, 2015NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Thursday, April 9, 2015NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Thursday, April 9, 2015DEATH OF INTERNATIONAL REGISTRATION
Saturday, August 23, 2014GENERIC MADRID TRANSACTION SENT TO IB
Saturday, August 23, 2014GENERIC MADRID TRANSACTION CREATED
Tuesday, May 6, 2014TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 6, 2013CANCELLED SECTION 71
Friday, November 30, 2007FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, January 10, 2007FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, January 10, 2007FINAL DISPOSITION PROCESSED
Monday, November 20, 2006FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 16, 2006REGISTERED-PRINCIPAL REGISTER
Tuesday, February 21, 2006PUBLISHED FOR OPPOSITION
Wednesday, February 1, 2006NOTICE OF PUBLICATION
Friday, December 23, 2005WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, November 23, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, November 18, 2005ASSIGNED TO LIE
Wednesday, November 9, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 7, 2005EXAMINERS AMENDMENT E-MAILED
Monday, November 7, 2005EXAMINERS AMENDMENT -WRITTEN
Tuesday, October 18, 2005TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 13, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 13, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 13, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 13, 2005ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 13, 2005TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 14, 2005ASSIGNED TO EXAMINER
Thursday, June 2, 2005REFUSAL PROCESSED BY IB
Thursday, April 14, 2005NON-FINAL ACTION MAILED
Wednesday, April 13, 2005NON-FINAL ACTION WRITTEN
Monday, April 11, 2005ASSIGNED TO EXAMINER
Tuesday, January 18, 2005NEW APPLICATION ENTERED IN TRAM
Thursday, January 13, 2005SN ASSIGNED FOR SECT 66A APPL FROM IB